Education
About Us
Working with TipRanks
Follow Us
Matinas BioPharma (MTNB)
:MTNB
Matinas BioPharma (MTNB) Ownership Overview
16.51%
Insiders
1.96% Mutual Funds
1.24% Other Institutional Investors
1.15% ETFs
79.14% Public Companies and Individual Investors
The ownership structure of Matinas BioPharma (MTNB) stock is a mix of institutional, retail, and individual investors. Approximately 4.34% of the company’s stock is owned by Institutional Investors, 16.51% is owned by Insiders, and 79.14% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 840,011 | Insider | 16.51% | 782,050 | |
| 128,956 | Institution | 2.54% | 120,058 | |
| 58,387 | Institution | 1.15% | 54,358 | |
| 58,387 | Institution | 1.15% | 54,358 | |
| 41,092 | Institution | 0.81% | 38,257 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 58,387 | Institution | 1.15% | 54,358 | |
| 41,092 | Institution | 0.81% | 38,257 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 58,387 | Institution | 1.15% | 47,585 |
FAQ
Who Owns Matinas BioPharma (MTNB)?
According to the latest TipRanks data, approximately 1.24% of the company's stock is held by institutional investors, 16.51% is held by insiders, and 79.14% is held by retail investors.
What percentage of Matinas BioPharma (MTNB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.24% of Matinas BioPharma (MTNB) stock is held by institutional investors.
What percentage of Matinas BioPharma (MTNB) stock is held by retail investors?
According to the latest TipRanks data, approximately 79.14% of Matinas BioPharma (MTNB) stock is held by retail investors.
Who owns the most shares of Matinas BioPharma (MTNB)?
Jerome D Jabbour owns the most shares of Matinas BioPharma (MTNB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.